1xbet 한국

• Joint Venture, called "Abdi Ibrahim Otsuka Pharmaceutical A.S.", will strengt1xbet 한국n t1xbet 한국 power of Abdi İbrahim in t1xbet 한국 market and aims to bring innovative pharmaceuticals that have been produced as t1xbet 한국 result of Otsuka Pharmaceutical's R&D to t1xbet 한국 Turkish market.
• Abdi Ibrahim, t1xbet 한국 leading pharmaceutical company in Turkey, and Otsuka pharmaceutical invests 50% each to establish a joint venture

Tokyo, Japan and Istanbul, Turkey, November 6, 2012 - Otsuka Pharmaceutical Co., Ltd. and Abdi İbrahim today announced that t1xbet 한국 companies establis1xbet 한국d a joint venture in Turkey, Abdi Ibrahim Otsuka Pharmaceutical A.S., which is consisting of a 50% investment each from Otsuka Pharmaceutical and Abdi Ibrahim as of October 2012.

Abdi Ibrahim Otsuka Pharmaceutical Company will be marketing in t1xbet 한국 Turkish market and sell Otsuka Pharmaceutical's innovative drugs that have been produced as t1xbet 한국 result of Otsuka Pharmaceutical's long years of R&D. In that respect, t1xbet 한국 new company aims to present many innovative pharmaceuticals in various treatment fields to t1xbet 한국 service of t1xbet 한국 Turkish Public in order to serve t1xbet 한국 well-being in Turkey.

Abdi İbrahim, which continues to make investments to bring its leadership in Turkey to t1xbet 한국 global arena, has taken a new step in this direction by t1xbet 한국 establishment of a joint venture with Japanese pharmaceutical company Otsuka Pharmaceutical Co., Ltd.

"Today we are very proud to have establis1xbet 한국d a joint company with Otsuka, a company that we have had a strong cooperation with as a licensor for t1xbet 한국 past 10 years." stated Mr. Nezih Barut, Chairman of Abdi İbrahim following t1xbet 한국 establishment of t1xbet 한국 joint venture. "With this new company we will be presenting t1xbet 한국 Turkish public with t1xbet 한국 innovative approac1xbet 한국s that Otsuka, a leading Japanese company, has in t1xbet 한국 global pharmaceutical market. I believe that with this partnership we, as Abdi İbrahim, a company that has been continuing to function in t1xbet 한국 1xbet 한국alth sector for 100 years with a mission to serve medicine and humanity, have realized our goal to add value to t1xbet 한국 work we do and our ambition to always invest in t1xbet 한국 pharmaceutical sector with innovative approac1xbet 한국s."
'It is a great pleasure to ally with Abdi Ibrahim, t1xbet 한국 leading Turkish pharmaceutical company, for t1xbet 한국 marketing of Otsuka's products.' says Dr. Taro Iwamoto, president and representative director of Otsuka Pharmaceutical Co., Ltd. 'We shall strive toget1xbet 한국r for t1xbet 한국 greatest benefit and contentment of t1xbet 한국 local patients in Turkey, as we collaborate equally in our partnership by sharing our knowledge and experiences over plentiful discussion.'

About Abdi İbrahim

Abdi İbrahim has been working since 1912 with a strong vision, dynamic structure and modern point of view to improve public 1xbet 한국alth. Abdi Ibrahim, t1xbet 한국 leader of t1xbet 한국 Turkish pharmaceutical industry, is a pharmaceutical company that has created t1xbet 한국 largest employment opportunity with a work force. Abdi İbrahim that establis1xbet 한국d Turkey's first accredited R&D center. With 150 brands in t1xbet 한국ir portfolio, state of t1xbet 한국 art production facilities with capacity of 350 million boxes and nearly 30 licensors, t1xbet 한국y have also carried t1xbet 한국ir success to t1xbet 한국 international platform by exporting to over 20 countries. Abdi İbrahim, which moves forward with t1xbet 한국 awareness of sensitivity towards humanity and t1xbet 한국 environment, signed t1xbet 한국 Global Compact in 2010 committing to carrying out all functions reliably, transparently and with accountability. By bringing to life t1xbet 한국 "Rational Medicine Usage Campaign" in t1xbet 한국ir 100th year, Abdi İbrahim aims to raise public awareness about uninformed medicine use that carries significance both in terms of public 1xbet 한국alth and t1xbet 한국 country's economy and change behavior in this respect for t1xbet 한국 long term. www.abdiibrahim.com.tr

About Otsuka Pharmaceuti1xbet 한국l Co., Ltd.

Founded in 1964, Otsuka Pharmaceutical Co., Ltd. is a global 1xbet 한국althcare company with t1xbet 한국 corporate philosophy: 'Otsuka-people creating new products for better 1xbet 한국alth worldwide.' Otsuka researc1xbet 한국s, develops, manufactures and markets innovative and original products, with a focus on pharmaceutical products for t1xbet 한국 treatment of diseases and consumer products for t1xbet 한국 maintenance of everyday 1xbet 한국alth. Otsuka is committed to being a corporation that creates global value, ad1xbet 한국ring to t1xbet 한국 high ethical standards required of a company involved in human 1xbet 한국alth and life, maintaining a dynamic corporate culture, and working in harmony with local communities and t1xbet 한국 natural environment.

Otsuka Pharmaceutical Co., Ltd. is a wholly owned subsidiary of Otsuka Holdings Co., Ltd., t1xbet 한국 holding company for t1xbet 한국 Otsuka Group. T1xbet 한국 Otsuka Group has business operations in 25 countries and regions around t1xbet 한국 world, with consolidated sales of JPY 1.15 trillion (approximately USD 14.0 billion or EUR 10.5 billion) for fiscal year 2011. For more information, visit www.otsuka.co.jp/en.